12
Phase 2–4 trials
Neuroscience · Live ClinicalTrials.gov data
Lecanemab (Leqembi) clinical trial pipeline
ClinicalTrials.gov lists 12 phase 2–4 trials for lecanemab, 3 of them actively recruiting. The next phase 3 primary completion among them is expected Dec 2028. Refreshed daily — add up to four competitors to compare pipelines side by side.
4
Phase 3 trials
3
Actively recruiting
Dec 2028
Next phase 3 primary completion
5,494
Participants across trials
Eisai Inc.
Lead sponsor by trial count
lecanemab (12)11 active2012–2032
lecanemab
'12
'14
'16
'18
'20
'22
'24
'26
'28
'30
'32
lecanemab
DIAN-TUP2
A Study to Evaluate Safety, Tolerability, and Efficacy of Lecanemab in Subjects With Early Alzheimer's DiseaseP2
Clarity ADP3
AHEAD 3-45 Study: A Study to Evaluate Efficacy and Safety of Treatment With Lecanemab in Participants With Preclinical Alzheimer's Disease and Elevated Amyloid and Also in Participants With Early Preclinical Alzheimer's Disease and Intermediate AmyloidP3
DIAN-TUP2
12-Month Real-World Safety & Efficacy of Lecanemab in Early Alzheimer's DiseaseP4
DIAN-TUP3
Deep Cervical Lymphatlc-Venous Anastomosis Surgery for the Treatment of Alzheimer's Disease: A Pilot Study (DIVA Study)P3
A Study of E2814 With Concurrent Lecanemab Treatment in Participants With Early Alzheimer's DiseaseP2
The Purpose of This Study is to Evaluate the Safety and Tolerability of X/T+X-EC in Participants With Alzheimer's Disease Who Are Currently Treated With Lecanemab.P2
Evaluating the Efficacy and Safety of Lecanemab in Alzheimer's Disease Through Multi-omics ApproachsP4
ECL-LecanemabP4
Upcoming readouts
9 ahead · lecanemab
Select a trial to load its full ClinicalTrials.gov record.
Key lecanemab trials
Top 12 of the 12 registered phase 2–4 trials, ordered by phase and status. Each links to its full ClinicalTrials.gov record.
| Trial | Title | Phase | Status | Primary completion |
|---|---|---|---|---|
| NCT07604896 | Evaluating the Efficacy and Safety of Lecanemab in Alzheimer's Disease Through Multi-omics Approachs | Phase 4 | Recruiting | Dec 2027 |
| NCT07688460 | ECL-Lecanemab — Evaluation System for Lecanemab Efficacy Using Gold Electrode ECL to Monitor Alzheimer's Biomarkers | Phase 4 | Recruiting | Mar 2029 |
| NCT07034222 | 12-Month Real-World Safety & Efficacy of Lecanemab in Early Alzheimer's Disease | Phase 4 | Active, not recruiting | Jan 2026 |
| NCT06530732 | Deep Cervical Lymphatlc-Venous Anastomosis Surgery for the Treatment of Alzheimer's Disease: A Pilot Study (DI… | Phase 3 | Recruiting | Jun 2026 |
| NCT04468659 | AHEAD 3-45 Study: A Study to Evaluate Efficacy and Safety of Treatment With Lecanemab in Participants With Pre… | Phase 3 | Active, not recruiting | Dec 2028 |
| NCT03887455 | Clarity AD — A Study to Confirm Safety and Efficacy of Lecanemab in Participants With Early Alzheimer's Disease | Phase 3 | Active, not recruiting | Jun 2029 |
| NCT06384573 | DIAN-TU — DIAN-TU Amyloid Removal Trial (ART) in Dominantly Inherited Alzheimer's Disease | Phase 3 | Active, not recruiting | Jun 2030 |
| NCT06602258 | A Study of E2814 With Concurrent Lecanemab Treatment in Participants With Early Alzheimer's Disease | Phase 2 | Active, not recruiting | Dec 2026 |
| NCT01760005 | DIAN-TU — Dominantly Inherited Alzheimer Network Trial: An Opportunity to Prevent Dementia. A Study of Potential Disease… | Phase 2 | Active, not recruiting | Apr 2028 |
| NCT05269394 | DIAN-TU — Dominantly Inherited Alzheimer Network Trial: An Opportunity to Prevent Dementia. A Study of Potential Disease… | Phase 2 | Active, not recruiting | Apr 2028 |
| NCT07212062 | The Purpose of This Study is to Evaluate the Safety and Tolerability of X/T+X-EC in Participants With Alzheime… | Phase 2 | Not yet recruiting | Apr 2028 |
| NCT01767311 | A Study to Evaluate Safety, Tolerability, and Efficacy of Lecanemab in Subjects With Early Alzheimer's Disease | Phase 2 | Completed | Dec 2024 |
Related drug pipelines
FAQ
- How many clinical trials are running for lecanemab?
- ClinicalTrials.gov currently lists 12 phase 2–4 lecanemab trials: 5 phase 2, 4 phase 3, and 3 phase 4. 3 are actively recruiting.
- Where does this data come from?
- All trial data is sourced from ClinicalTrials.gov (CTGov) and refreshed on this page daily.
- Can I compare lecanemab against other drugs?
- Yes. The free ComplyRx Trial Pipeline tool compares up to five drugs side by side on one timeline, with PNG and PDF export. Add any competitor in the search box above.
Join the waitlist
Be the first to access ComplyRx
We'll let you know as soon as your spot opens to use ComplyRx.
By joining, you agree to our Privacy Policy.